Paper668802
Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes.
Van Snick JL and 4 others. Eur J Immunol, 1978. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes. Papers, record 668802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/668802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhancement by IgM rheumatoid factor of in vitro ingestion by macrophages and in vivo clearance of aggregated IgG or antigen-antibody complexes.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophages | Major topic |
| Phagocytosis | Major topic |
| Rheumatoid Factor | Major topic |
| Animals | |
| Antigen-Antibody Complex | |
| Arthritis, Rheumatoid | |
| Complement System Proteins | |
| Female | |
| Humans | |
| Immunoglobulin G | |
| Mice | |
| Mice, Inbred Strains | |
| Monocytes |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42136488 | Rheumatoid Arthritis: A Comprehensive Review of Etiology, Pathophysiology, and Innovative Therapeutic Advancements. | Curr Pharm Des | 2026 | https://conductscience.org/library/papers/42136488 | PubMed |
| 40094988 | Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid Arthritis. | J Clin Med | 2025 | https://conductscience.org/library/papers/40094988 | PubMed |
| 39835117 | Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. | Front Immunol | 2024 | https://conductscience.org/library/papers/39835117 | PubMed |
| 38487524 | Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/38487524 | PubMed |
| 37956528 | Novel and unique rheumatoid factors cross-react with viral epitopes in COVID-19. | J Autoimmun | 2024 | https://conductscience.org/library/papers/37956528 | PubMed |
| 33546243 | Rheumatoid Factor: A Novel Determiner in Cancer History. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33546243 | PubMed |
| 33445768 | From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33445768 | PubMed |
| 33327600 | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics. | Biomolecules | 2020 | https://conductscience.org/library/papers/33327600 | PubMed |
| 31845355 | Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology. | Immunol Rev | 2020 | https://conductscience.org/library/papers/31845355 | PubMed |
| 30858306 | Cardiac phenotype in mouse models of systemic autoimmunity. | Dis Model Mech | 2019 | https://conductscience.org/library/papers/30858306 | PubMed |
| 25962087 | Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity. | MAbs | 2015 | https://conductscience.org/library/papers/25962087 | PubMed |
| 25566247 | Neutralization-Enhancing RF Antibodies for HIV Vaccines. | Front Immunol | 2014 | https://conductscience.org/library/papers/25566247 | PubMed |
| 23351360 | A rheumatoid factor paradox: inhibition of rituximab effector function. | Arthritis Res Ther | 2013 | https://conductscience.org/library/papers/23351360 | PubMed |
| 19926660 | Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies. | QJM | 2010 | https://conductscience.org/library/papers/19926660 | PubMed |
| 9151704 | Role of repetitive antigen patterns for induction of antibodies against antibodies. | J Exp Med | 1997 | https://conductscience.org/library/papers/9151704 | PubMed |
| 8793270 | Rheumatoid factor in patients with systemic lupus erythematosus. | Clin Rheumatol | 1996 | https://conductscience.org/library/papers/8793270 | PubMed |
| 7809146 | Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7809146 | PubMed |
| 7327699 | Rheumatoid factor and monosodium urate crystal-neutrophil interactions in gouty inflammation. | Inflammation | 1981 | https://conductscience.org/library/papers/7327699 | PubMed |
| 6976413 | Monoclonal anti-IgG autoantibodies derived from lipopolysaccharide-activated spleen cells of 129/Sv mice. | J Exp Med | 1982 | https://conductscience.org/library/papers/6976413 | PubMed |
| 6974064 | In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6974064 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/668802
GET https://conductscience.org/api/papers/v1/668802/cited_by?page=2